Camurus AB (publ) (STO:CAMX)
Sweden · Delayed Price · Currency is SEK 573.00
-12.00 (-2.05%)
Jul 3, 2026, 5:29 PM CET
Camurus AB Market Cap
Camurus AB has a market cap or net worth of 34.1 billion as of July 2, 2026. Its market cap has decreased by -2.52% in one year.
Market Cap
34.10B
Enterprise Value
30.33B
Revenue
2.24B
Ranking
n/a
PE Ratio
50.47
Stock Price
573.00
Market Cap Chart
Since December 3, 2015, Camurus AB's market cap has increased from 1.66B to 34.10B, an increase of 1,949.49%. That is a compound annual growth rate of 33.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 34.10B | -7.18% |
| Dec 30, 2025 | 36.74B | 10.34% |
| Dec 30, 2024 | 33.30B | 11.26% |
| Dec 29, 2023 | 29.93B | 113.76% |
| Dec 30, 2022 | 14.00B | 69.32% |
| Dec 30, 2021 | 8.27B | -18.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioArctic AB | 28.89B |
| Hansa Biopharma AB | 3.57B |
| Vicore Pharma Holding AB | 3.40B |
| Egetis Therapeutics AB | 3.00B |
| Flerie AB | 1.98B |
| Saniona AB | 1.78B |
| BioInvent International AB | 1.61B |
| Genovis AB (publ.) | 1.35B |